Insperity Q3 revenue reaches USD 1,651 million
Insperity reported Q3 revenue of USD 1,651 million, versus the IBES estimate of USD 1,636 million.
Related stories
BioMarin Signs Fabry Disease Treatment Development Deal
BioMarin signed an agreement with GC Biopharma and Hanmi to develop a treatment for Fabry disease.
M impact | EQUITY | Oct 29, 2026, 12:49 PM UTC
Alnylam Q3 Non-GAAP Net Income and Revenue Rise; 2026 Outlook Kept
M impact | EQUITY | Oct 29, 2026, 12:49 PM UTC
National Medical Care says quarterly surgeries rose 16.7%
M impact | EQUITY | Oct 29, 2026, 12:48 PM UTC
Desjardins to Acquire 100% of Bennington Shares at About 8% Discount
EQB Inc. said Desjardins will acquire all Bennington shares at a price equivalent to a discount of about 8% of lease receivables.
M impact | EQUITY | Oct 29, 2026, 12:47 PM UTC
Microsoft Prepares to Issue at Least $25 Billion in Bonds
Microsoft is moving to issue at least $25 billion in new bonds, according to investors, to fund its AI buildout. The sale would be its first since 2017.
M impact | EQUITY | Oct 29, 2026, 12:46 PM UTC
Newmark Reports Third-Quarter 2026 Financial Results
Newmark scheduled a conference call to discuss the results for 10:00 a.m. ET today.
M impact | EQUITY | Oct 29, 2026, 12:45 PM UTC